Transperineal prostate biopsy
Biopsy through the perineum instead of the rectum.
Key point
Transperineal biopsy is the recommended approach when technically feasible.
From: French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes (Fr J Urol, 2025 Dec) ↗Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 9, 6, 13, 12, 19.
New guidelines and consensus this year
- The Italian Society of Urology Statement on focal therapy for localized prostate cancerMinerva Urol Nephrol2026 Feb
- Perioperative and Peri-Interventional Antibiotic Prophylaxis in Urology: Key Recommendations from the German Interdisciplinary AWMF S3 Clinical Practice GuidelineUrol Int2026 Jan 21
- French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changesFr J Urol2025 Dec
All papers from the last 12 months
217 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Reply to Drs. Bayraktar and İşler's Letter to the Editor re: Basadonna LM, Passarelli F, Graps G, et al. Music During Transperineal Prostate Biopsy (The VIVALDI Trial): A Few Questions on the Gap Between Self-reported Benefit and Objective FindingsEur Urol Open Sci2026 NovPMID 42828258
- Can prostate cancer be diagnosed with near certainty on MRI?Eur J Radiol2026 NovPMID 42531699
- Validation of AI-derived whole prostate volumetry versus ellipsoid formula for PSA density-based risk stratificationEur J Radiol2026 NovPMID 42447771
- Perilesional biopsy in - systematic out? Comparative analysis of targeted, perilesional and systematic core yield by needle tracking with robotic-assisted transperineal MRI/US fusion prostate biopsyUrology2026 Oct 9PMID 42854856
- Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography / Magnetic Resonance Imaging in Selected Men with Equivocal Prostate Imaging Reporting and Data System Category 3 Lesion (PANDORA): A Prospective Paired Diagnostic StudyJ Urol2026 Oct 8PMID 42849042
- Are template prostate biopsies still required in patients with high-risk PI-RADS lesions? A retrospective study of 470 patientsBJUI Compass2026 OctPMID 42841147
- Pain and patient-reported experience after freehand transperineal prostate biopsy under local anaesthesiaBJUI Compass2026 OctPMID 42831196
- Prospective Comparison of Cognitive MRI-Targeted Biopsy Under Micro-Ultrasound Guidance Versus MRI/Ultrasound Fusion-Guided Transperineal Biopsy for Clinically Significant Prostate Cancer DetectionJ Clin Med2026 Oct 2PMID 42882109
- Predicting clinically significant prostate cancer in PI-RADS 3 lesions: an internally validated PSA density-based model with decision-curve analysisInt Urol Nephrol2026 Oct 2PMID 42827186
- Factors Associated with Pain During Transperineal Prostate Fusion Biopsy Under Local Anaesthesia: A Prospective StudyDiagnostics (Basel)2026 Oct 1PMID 42882350
More urology trends
All specialties →Minimally invasive BPH treatments
Water vapour therapy, urethral lift, aquablation and prostatic artery embolisation.
Antibody-drug conjugates in bladder cancer
Enfortumab vedotin and other ADCs in urothelial cancer.
Key point: Enfortumab vedotin-related adverse events, particularly cutaneous toxicity, were associated with favorable clinical outcomes, but findings are hypothesis-generating and need prospective confirmation.
MRI in prostate cancer diagnosis
MRI before biopsy and in screening for prostate cancer.
Thulium fibre laser
Thulium fibre laser for stone lithotripsy and prostate surgery.
Key point: ThuFLEP and conventional HoLEP are clinically comparable, with no definitive superiority of either laser.
PSMA PET in prostate cancer
PSMA PET imaging for staging and recurrence of prostate cancer.
Key point: PSMA-PET/CT is recommended only when PSA exceeds 0.2 μg/L, reporting should follow PSMA-RADS, and it is preferred over lymph-node dissection for staging.
Male infertility
Male infertility and trends in semen quality.
Key point: Male infertility management should be couple-centered, integrating the female partner's reproductive timeline to avoid preventable delays in effective therapy.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
transperineal[tiab] AND biopsy[tiab] AND prostate[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.